Tavapadon (Juvmo) is a new once-daily pill for Parkinson’s motor symptoms. Here’s how it works, who it may help and what to ...
Path to Prevention (P2P) is a Phase 2A platform trial that leverages Parkinson’s Precision Medicine Initiative (PPMI) infrastructure to evaluate investigational products in participants with neuronal ...
Changes in walking, mobility and balance can be frustrating symptoms of Parkinson’s disease. Join this month’s MJFF Parkinson’s Webinar to hear our panel of experts discuss why gait changes occur in ...
On September 9, 2026, Michael J. Fox received the 2026 Lasker~Bloomberg Public Service Award, one of the nation’s highest honors in biomedical science, recognizing his work to empower the voices of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results